HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Arden Revs Up Daytona 500 Launch With Ad Campaign

This article was originally published in The Rose Sheet

Executive Summary

Elizabeth Arden is supporting the launch of Daytona 500 fragrance for men with a targeted advertising campaign that will include TV, print and radio spots, according to the beauty marketer

You may also be interested in...



Arden Sales Projected To Grow 8%-12% In First Half Of ’06

Elizabeth Arden anticipates revenues in the first half of FY 2006 to increase 8%-12%, reflecting the "timing of brand development and marketing expenditures" relating to the launch of Allergan's PREVAGE anti-aging skin care, as well as initiatives under the Britney Spears fragrance franchise, the firm reported Aug. 11

Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States

Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.

Fenty Cleanser Performance Claims Supported, But Influencer Videos Need Disclaimers – NAD

A National Advertising Division review of claims by LVMH-owned Fenty Skin determined makeup- and dirt-removal representations were substantiated by a study and subject questionnaire, but demo videos from paid endorsers must include disclosures about material connections in accordance with FTC guidelines.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013732

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel